FILES-BRITAIN-HEALTH-VIRUS-PHARMACEUTICAL-BUSINESS

(FILES) Vials of the AstraZeneca/Oxford Covid-19 vaccine, also called Vaxzervria, destined for housebound patients, are pictured at Stubley Medical Centre near Chesterfield, central England on April 14, 2021. - British drugmaker AstraZeneca said on May 8, 2024 that it has withdrawn its Covid vaccine Vaxzervria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs. "As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines. This has led to a decline in demand for Vaxzervria, which is no longer being manufactured or supplied," an AstraZeneca spokeperson said. (Photo by OLI SCARFF / AFP)

PBBM unveils new onion cold storage facility, Super Health Center in Isabela visit

PBBM signs law resetting BARMM polls to September 2026

ERC orders temporary suspension of electricity market ops amid energy emergency

DND champions cross-regional security cooperation with NATO, European partners

Popular Articles

PBBM leads turnover of SPIPs, CamSur Food Complex to Bicol farmers

Sustainable tourism: Filipino-made e-Tranvia to trace Intramuros

PCUP, PhilFIDA explore joint livelihood programs for urban poor

Latest Articles

PBBM unveils new onion cold storage facility, Super Health Center in Isabela visit

PBBM signs law resetting BARMM polls to September 2026

ERC orders temporary suspension of electricity market ops amid energy emergency

Address

Other Links